Information and communication technology based prompting for treatment compliance for people with serious mental illness

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 6, 2014, Pages

  Kauppi, Kaisa ^a   Välimäki, Maritta ^a   Hätönen, Heli M ^a   Kuosmanen, Lauri M ^a   Warwick Smith, Katja ^a   Adams, Clive E ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEPRESSION; DISEASE SEVERITY; HEALTH CARE UTILIZATION; HUMAN; INFORMATION TECHNOLOGY; MEDICATION COMPLIANCE; MENTAL HEALTH; MENTAL PATIENT; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RELAPSE; REVIEW; SYSTEMATIC REVIEW; TEXT MESSAGING; ADULT; MENTAL DISORDERS; META ANALYSIS; PATIENT COMPLIANCE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMINDER SYSTEM;

ADULT; HUMANS; MEDICATION ADHERENCE; MENTAL DISORDERS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMINDER SYSTEMS; TEXT MESSAGING;

EID: 84910133941     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009960.pub2     Document Type: Review

References (87)

1. Hulsbosch AM, Kroon H. Randomised controlled trial of home automation in mental health. Available from http: //www.trialregister.nl/trialreg/index.asp 2008.
2. Maurino J, Tesoro A, Diez T, Gomez-Beneyto M. Short message service (SMS)-based strategy to improve antipsychotic adherence among patients with schizophrenia. Value in Health 2010:242.
3. Montes JM, Gmez Beneyto M, Tesoro A, Dez T, Maurino J. Short message service (sms)-based strategy to improve antipsychotic adherence in schizophrenia. 19th European Congress of Psychiatry, Vienna 2011.
4. Montes JM, Medina E, Gomez-Beneyto M, Maurino J. A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia. Psychiatry Research 2012;200(2-3):84-95. [PUBMED: 22901437]
5. Burgoyne RW, Acosta FX, Yamamoto J. Telephone prompting to increase attendance at a psychiatric outpatient clinic. American Journal of Psychiatry 1983;140:345-7. [MEDLINE: 6829808]
6. Cramer JA, Rosenheck R. Enhancing medication compliance for people with serious mental illness. Journal of Nervous and Mental Disease 1999;187(1):53-5. [MEDLINE: 9952254]
7. Crespo-Iglesias JM, Gonzalez Garcia A, Santos Miguelez B, Naya Fernandez S. Improvement of the attendance to the first psychiatric appointments after telephone reminder [Mejoria de la asistencia a las primeras citas en psiquiatria tras aviso telefonico]. Anales de Psiquiatria 2006;22(3):95-101. [MEDLINE: 1254142]
8. Frangou S, Sachpazidis I, Stassinakis A, Sakas G. Telemonitoring of medication adherence in patients with schizophrenia. Telemedicine Journal and E-Health 2005;11(6):675-83. [MEDLINE: 16430387]
9. Hansson L, Svensson B, Bjorkman T, Bullenkamp J, Lauber C, Martinez-Leal R, et al.What works for whom in a computer-mediated communication intervention in community psychiatry? Moderators of outcome in a cluster randomized trial. Acta Psychiatrica Scandinavica 2008;118(5):404-9. [MEDLINE: 18759805]
10. Kluger MP, Karras A. Strategies for reducing missed initial appointments in a community mental health center. Community Mental Health Journal 1983;19:137-43. [MEDLINE: 6653081]
11. Lassen WE. The effects of acceptance and commitment therapy (act) on anxiety in people with psychosis. Sciences and Engineering 2011;71(11-B):7093. [: MEDLINE]
12. MacDonald J, Brown N, Ellis P. Using telephone prompts to improve initial attendance at a community mental health centre. Psychiatric Services 2000;51(6):812-4. [MEDLINE: 10828117]
13. Montes J, Saiz Ruiz J, Claret J, Maurino J, Diez T. Effect of a nurse telephone follow-up on therapeutic adherence of patients with schizophrenia. World Psychiatry 2009; Vol. 8, issue Suppl 1.
14. Nietert PJ, Tilley BC, Zhao W, Edwards PF, Wessel A, Mauldin PD, et al.Two pharmacy interventions to improve refill persistence for chronic disease medications. A randomized controlled trial. Medical Care 2009; Vol. 47:32-40.
15. Pijnenborg GHM, Withaar FK, Brouwer WH, Timmerman ME, van den Bosch RJ, Evans JJ. The efficacy of SMS text messages to compensate for the effects of cognitive impairments in schizophrenia. British Journal of Clinical Psychology 2010;49:259-74.
16. Rossi E. Effects of a simple strategy on attendance and satisfaction with medication clinic services in the chronically mentally ill. PhD dissertation submitted to the United States International University, USA 1994:103.
17. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology 2011;217(2):279-87. [MEDLINE: BIOSIS:PREV201100612187]
18. Velligan DI, Diamond PM, Mintz J, Maples N, Li X, Zeber J, et al.The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophrenia Bulletin 2008; Vol. 34, issue 3:483-93.
19. Berns S. Electronic assistive device to help patients with schizophrenia. National Alliance for Research on Schizophrenia and Depression. Available from http: //www.mhsource.com/narsad/bd/studyops.html 2001.
20. Välimäki M. Mobile telephone text messages to encourage compliance with medication and to follow up with people with psychosis: A multi-centre randomised controlled two armed trial. http://www.controlled-trials.com/ISRCTN27704027 2011. [DOI: 10.1186/ISRCTN27704027]
21. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200.
22. Amador XF, Strauss DH, Yale SA. Awareness of illness in schizophrenia. Schizophrenia Bulletin. 1991;17(1):113-32. [MEDLINE: 2047782]
23. Amador XE, Flaum M, Andreasen NC. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Archives of General Psychiatry 1994;51(10):826-36. [PUBMED: 7944872]
24. Anderson KH, Ford S, Robson D, Cassis J, Rodrigues C, Gray R. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia. International Journal of Mental Health Nursing 2010;19(5):340-9. [PUBMED: 20887608]
25. Atherton H, Car J, Meyer B. Email for the management of healthcare appointments and attendance reminders. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD007981]
26. Berkman ET, Dickenson J, Falk EB, Lieberman MD. Using SMS text messaging to assess moderators of smoking reduction: Validating a new tool for ecological measurement of health behaviors. Health Psychology 2011;30(2):186-94. [PUBMED: 21401252]
27. Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600. [PUBMED: 9302962]
28. Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al.The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'etude des Indices d'efficacite]. Therapie 1999;54(4):405-11. [PUBMED: 10667106]
29. Brooks R. EuroQol: the current state of play. Health Policy 1996;37(1):53-72. [PUBMED: 10158943]
30. Buchanan RW, Carpenter WT. Concept of schizophrenia. In: Sadock BJ, Sadock VA editor(s). Kaplan & Sadocks Comprehensive Textbook of Psychiatry. 8th Edition. Vol. II, Philadelphia, USA: Lippincott Williams & Wilins, 2005:1329-45.
31. de Jong Gierveld J, van Tilburg T. Manual of the Loneliness Scale. http://home.fsw.vu.nl/tg.van.tilburg/manual_loneliness_scale_1999.html 1999.
32. Deeks J. Issues in the selection for meta-analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town. Cape Town: The Cochrane Collaboration, 2000.
33. Department of Health, Victorian Government, Melbourne. Mental Health Bill 2010, Information sheet 1: Supported decision making, improving patient participation and carer involvement. http: //www.health.vic.gov.au/mentalhealth/mhactreview/information_sheet1.pdf (accessed 15 August 2011).
34. Department of Health. Missed appointments guidance. GP Bulletin 2004, issue 33.
35. Department of Health. The NHS Choices Annual Report 2010. http: //www.nhs.uk/aboutNHSChoices/professionals/developments/Documents/annual-report/annual-report-2010.pdf (accessed 15 August 2011).
36. Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623-9. [PUBMED: 1453246]
37. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21(19):2971-80. [PUBMED: 12325113]
38. Eby L, Brown N. Mental Health Nursing Care. New Jersey: Pearson Education, 2005.
39. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
40. Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A. Meta-analyses involvingcross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
41. European Union. European pact for mental health and well-being. EU high-level conference Together for mental health and wellbeing 2008.
42. Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. American Journal of Preventive Medicine 2009;36(2):165-73.
43. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(7):7-10.
44. Brozek J, Oxman J, Schunemann H. GRADEpro. Version 3.2 for Windows. Cochrane IMS, 2008.
45. Gulliford MC. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876-83.
46. Guy W. Clinical Global Impression (CGI). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD, U.S. Department of Health, Education, and Welfare 1976.
47. Hatcher RL, Gillaspy JA. Development and validation of a revised short version of the working alliance inventory. Psychotherapy Research 2006;16:12-25.
48. Haug S, Meyer C, Schorr G, Bauer S, John U. Continuous individual support of smoking cessation using text messaging: a pilot experimental study. Nicotine & Tobacco Research 2009;11(8):915-23.
49. Hospital Episode Statistics:Hospital Outpatient Activity 2011-12 Summary report. https://catalogue.ic.nhs.uk/publications/hospital/outpatients/hosp-outp-acti-11-12/hosp-outp-acti-11-12-summ-repo-rep.pdf.
50. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
51. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
52. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine 1983;13:177-83.
53. Hong J, Windmeijer F, Novick D, Haro JP, Brown J. The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Helath Outcomes) study. Progress in Neuro-Psychopharmacalogy & Biological Psychiatry 2009;33:835-41.
54. Hutton JL. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology 2009;146(1):27-30.
55. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.
56. Kerzman T, Kok I, Wijngaarden B. De GGZ Thermometer Nader Onderzocht: De Evaluatie van een Vragenlijstvoor Cliëntwaardering in de Volwassenenzorg. Trimbos-instituut, Utrecht, 2003.
57. Kitcheman J, Adams CE, Pervaiz A, Kader I, Mohandas D, Brookes G. Does an encouraging letter encourage attendance at psychiatric out-patient clinics? The Leeds PROMPTS randomized study. Psychological Medicine 2008;5:717-23.
58. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean?. Schizophrenia Research 2005;79(2-3):231-8. [PUBMED: 15982856]
59. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry 2005;187:366-71. [PUBMED: 16199797]
60. Leucht S, Engel RR, Bauml J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF?. Schizophrenia Bulletin 2007;33(1):183-91. [PUBMED: 16905632]
61. MacDonald J, Brown N, Ellis P. Using telephone promts to improve initial attendance at a community mental health centre. Psychiatric Services 2000;51(6):812-4.
62. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52.
63. McIntosh AM, Conlon L, Lawrie SM, Stanfied AC. Compliance therapy for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD003442.pub2]
64. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care 1986;24(1):67-74.
65. Mulder CL, Staring ABP, Loos J, Buwalda V, Kuijpers D, Sytema S, et al.De Health of the NationsOutcome Scale (HoNOS) als instrument voor 'routine outcome assessment. Tijdschrift voor Psychiatrie. 2004;46(5):273-85.
66. Mulder CL, Staring ABP, Loos J, Buwalda VJA, Kuijpers D, Sytema S, et al.No English title found [De Health of the NationsOutcome Scale (HoNOS) in Nederlandse bewerking: Handleiding Rotterdam: O3 Onderzoekscentrum GGZ Rijnmond. 2004b]. http://www.euronet.nl/sogg/honos.htm 2004.
67. Munder T, Wilmers F, Leonhart R, Linster HW, Barth J. Working Alliance Inventory-Short Revised (WAISR): psychometric properties in outpatients and inpatients. Clinical Psychology and Psychotherapy 2010;17(3):231-9. [DOI: 10.1002/cpp.658]
68. National Institute for Health and Clinical Excellence. Schizophrenia. Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care. Available from http: //www.nice.org.uk 2009.
69. Nicholl D, Akhras K, Diels J, Schadrack J. Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective. Current Medical Research & Opinion 2010;26(4):943-55.
70. Nieuwenhuizen CV, Schene A, Boevink W, Wolf J. The Lancashire Quality of Life Profile: First experiences in The Netherlands. Community Mental Health Journal 1998;34(5):513-24.
71. Nieuwenhuizen C, Schene AH, Koeter MWJ, Huxley PJ. The Lancashire Quality of Life Profile: modification and psychometric evaluation. Social Psychiatry and Psychiatric Epidemiology 2001;36(1):36-44.
72. Oliver JP. The Social Care Directive: development of a quality of life profile for use in community services for the mentally ill. Social Work and Social Sciences Review 1991;3:5-45.
73. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports 1962;10:799-812.
74. Potosky D, Bobko P. The Computer Experience and Understanding Scale: a self-report measure of computer experience. Computers in Human Behavior 1998;14:337-48.
75. Priebe S, Huxley P, Knight S, Evans S. Application and results of the Manchester Short Assessment of Quality of Life (MANSA). International Journal of Social Psychiatry 1999;45(1):7-12. [PUBMED: 10443245]
76. Reda S, Rowett M, Makhoul S. Prompts to encourage appointment attendance for people with serious mental illness. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD002085]
77. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, et al.Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of Psychiatry 1999;56(3):241-7.
78. Sawyer SM, Zalan A, Bond LM. Telephone reminders improve adolescent clinic attendance: A randomised controlled trial. Journal of Paediatrics and Child Health 2002;38(1):79-83.
79. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al.Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008:359-83.
80. Sims H, Sanghara H, Hayes D, Wandiembe S, Finch M, Jakobsen H, Tsakanikos E, Okocha CI, Kravariti E. Text message reminders of appointments: a pilot intervention at four community mental health clinics in London. Psychiatric Services 2012;36(2):161-8. [PUBMED: 22302334]
81. Slade M, Beck A, Bindman J, Thornicroft G, Wright S. Routine clinical outcome measures for patients with severe mental illness: CANSAS and HoNOS. British Journal of Psychiatry 1999;174:404-8. [PUBMED: 10616605]
82. Thi Phan T. Enhancing client adherence to psychotropic medication regiments: a psychosocial nursing approach. International Journal of Psychiatric Nursing Research 1995;2(1):147-72.
83. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1-75.
84. van Wijngaarden B, Kok I, Meije D, Fotiadis L. Een Consumer Quality Index voor Kortdurende Ambulante GGZ: De ontwikkeling en Psychometrische Kwaliteiten van een Vragenlijst voor het Meten van Cliëntervaringen - Verslag van een Pilotstudie. http://www.centrumklantervaringzorg.nl/fileadmin/site/ckz/publicaties/CQI_ambulante_GGZ.pdf. Trimbos-instituut, Utrecht.
85. World Health Organization. WHO Resource Book on Mental Health, Human Rights and Legislation. Stop Exclusion, Dare to Care. World Health Organization, 2005.
86. World Health Organization. Schizophrenia. http: //www.who.int/mental_health/management/schizophrenia/en/ (accessed 15 August 2011).
87. Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al.Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin 2009;33(7):254-7.